Acquired by French global healthcare giant Sanofi in 2011, Genzyme has made the security of its physical and intellectual assets a priority since the 1990s, and was among the first companies to define ...

The possibility that France may block a deal between Sanofi and ... of reinforcing global supply chains of medicines based on ...

As Saudi Arabia moves toward healthcare self-sufficiency under Vision 2030, the localization of vital pharmaceutical manufacturing has become a critical priority. In a major step forward, Sanofi, ...

SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity of their 21-valent pneumococcal conjugate vaccine candidate, GBP410 ...

Analyst Graham Parry of Bank of America Securities reiterated a Buy rating on Sanofi (SNYNF – Research Report), boosting the price target to ...

Sanofi and Boehringer Ingelheim (BI), drug giants from Europe, have sought for local regulatory clearances from the Competition Commission of India (CCI), so that it can complete the global asset ...